Market Tracker

02/12 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.08
Delayed Data
As of Feb 12
 -0.05 / -4.42%
Today’s Change
1.08
Today|||52-Week Range
4.40
-34.15%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.13
Today’s open1.12
Day’s range1.08 - 1.14
Volume66,439
Average volume (3 months)126,273
Market cap$31.0M
Dividend yield--
Data as of 3:59pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)-17.95%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
TROVUTrovagene Inc0.000.00%
AVDXAvant Diagnostics In...0.000.00%
TTHITransition Therapeut...0.000.00%
INISInternational Isotop...-0.01-9.91%
Data as of 3:59pm ET, 02/12/2016

Financials

Next reporting dateMarch 16, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts